Cholesterol inhibition, cancer, and coronary heart disease
- 11 July 1992
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 340 (8811) , 127-128
- https://doi.org/10.1016/0140-6736(92)90461-b
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Serum Cholesterol and Cancer Risk: An Epidemiologic PerspectiveAnnual Review of Nutrition, 1992
- The cholesterol controversy.BMJ, 1992
- The prenylation of proteinsCurrent Opinion in Lipidology, 1991
- Expanded Clinical Evaluation of Lovastatin (EXCEL) Study ResultsArchives of internal medicine (1960), 1991
- Lovastatin decreases coenzyme Q levels in humans.Proceedings of the National Academy of Sciences, 1990
- Expanded clinical evaluation of lovastatin (EXCEL) study: Design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesterolemiaThe American Journal of Cardiology, 1990
- Diet-induced reduction in serum lipoproteins stimulates cell proliferation in weanling ratsPharmacological Research, 1989
- Lipid Composition and De Novo Cholesterogenesis in Normal and Neoplastic Rat Mammary TissuesJNCI Journal of the National Cancer Institute, 1988
- HMG-CoA Reductase Inhibitors for Treatment of HypercholesterolemiaNew England Journal of Medicine, 1988
- INCIDENCE OF CANCER IN MEN ON A DIET HIGH IN POLYUNSATURATED FATThe Lancet, 1971